The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6
Sign Up to like & getrecommendations! Published in 2018 at "Experimental Neurology"
DOI: 10.1016/j.expneurol.2018.07.005
Abstract: Abstract Parkinson's disease (PD), the second most common age‐related progressive neurodegenerative disorder, is characterized by dopamine depletion and the loss of dopaminergic (DA) neurons with accompanying neuroinflammation. Zonisamide is an‐anti‐convulsant drug that has recently been… read more here.
Keywords: zonisamide reduces; zonisamide; microglial nav; drug ... See more keywords